CTEV

Claritev Corp
7 filings tracked
healthcarehealthcare data analyticsMID ($2B-10B)

Signal Magnitude Chart

BEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionBEARISH | 70% | 5/7/2026 | earnings missBULLISH | 60% | 5/7/2026 | margin expansionBEARISH | 40% | 5/7/2026 | dilution riskBEARISH | 50% | 5/7/2026 | regulatory actionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%